Competitor Analysis: Ras-Raf-MEK-ERK InhibitorsLa Merie PublishingJune 1, 2011 75 Pages - SKU: LAM6404209 |
|
The World Market for Pain Management Drugs and Devices
5/20/2013 | published by: Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and
|
read more...
|
$3,500.00
|
|
Competitor Analysis: Coagulation Factors
5/1/2013 | published by: La Merie Publishing
Competitor Analysis: Coagulation Factors
Product description
The Competitive Intelligence Report Coagulation Factors provides a competitor analysis of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or
|
read more...
|
$800.00
|
|
Hypertension Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for hypertension treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic
|
read more...
|
$2,000.00
|
|
Anti-Obesity Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for anti-obesity drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends,
|
read more...
|
$2,000.00
|
|
Osteoporosis Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for osteoporosis treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's
|
read more...
|
$2,000.00
|
|
Anti-Tumor Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for anti-tumor drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends,
|
read more...
|
$2,000.00
|
|
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players
5/15/2013 | published by: GlobalData
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players”. The report is a vital source of up-to-date information with
|
read more...
|
$2,995.00
|
|
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
5/15/2013 | published by: GlobalData
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is
|
read more...
|
$3,495.00
|
|
Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
5/15/2013 | published by: GlobalData
Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is
|
read more...
|
$3,495.00
|
|
Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
5/15/2013 | published by: GlobalData
Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is
|
read more...
|
$3,495.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Drug Discovery Reports
- Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially Supplemented by Approvals for Alzheimer’s Disease
- Central Nervous System Disorder Drugs Markets in China
- Lymphoma Treatment Drugs Markets in China
- Anti-Tumor Drugs Markets in China
- Osteoporosis Treatment Drugs Markets in China